Novartis, Roche Near US Drug Price Deal as Tensions Ease (1)

December 18, 2025, 8:36 AM UTC

The White House is set to announce drug pricing deals with pharmaceutical heavyweights Novartis AG and Roche Holding AG as soon as Friday, according to people familiar with the situation, further easing trade tensions with Switzerland after a standoff over tariffs.

Other drugmakers could also be included in the announcement, and the details remain in flux, the people said. Pfizer Inc., AstraZeneca Plc and other companies have struck deals with the Trump administration in recent months, agreeing to lower prices in certain instances in return for relief from tariffs.

Shares of both Roche and Novartis slipped about 0.7% in ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.